Bhimavaram Institute Of Oncology Private Limited - Company Profile

It is a healthcare private limited company based in Bhimavaram, Andhra Pradesh, India, established in 2020.
2020 Bhimavaram, Andhra Pradesh, India Active
Last Updated:
Access Report
About Bhimavaram Institute Of Oncology Private Limited

Bhimavaram Institute Of Oncology Private Limited, a active private limited company, was established on 21 August 2020 in Bhimavaram, Andhra Pradesh, India. Engaging in preventive health services within the healthcare sector, it holds CIN: U85100AP2020PTC115422. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹8.50 Cr.

It upholds a compliant status. Employing 43 professional, Its leadership includes Hara Govind Chigurupati (Director), Gopala Raju Gadiraju (Director), Venkata Naga Murali Krishnam Raju Kunaparaju (Managing Director). Past directors included Hara Govind Chigurupati, Sridhar Peddireddy. It holds ₹10.65 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at C/O Kvnmk Raju,Bhimavaram Hospitals Ltd, Opp S R K R Engg. College, W.G.District, Bhimavaram, Andhra Pradesh, 534201.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85100AP2020PTC115422

  • Registration Number

    115422

  • Incorporation Date

    21 August 2020

  • Authorized Capital

    ₹10.00 Cr

  • Paid-Up Capital

    ₹8.50 Cr

  • ROC Code

    Roc Vijayawada

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 10.00 Cr
  • Paid Up Capital ₹ 8.50 Cr
  • Company Age 5 Year, 6 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 10.65 Cr
  • Revenue Growth **** %
  • Ebitda ****
  • Net Worth 335.70%
  • Total Assets **** 15667.49%
Company report

Bhimavaram Institute Of Oncology Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Bhimavaram Institute Of Oncology Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Bhimavaram Institute Of Oncology Private Limited?
Current Directors
Name Designation Appointment Date Status
Hara Govind Chigurupati Director 01 Oct 2021 Current
Gopala Raju Gadiraju Director 21 Aug 2020 Current
Venkata Naga Murali Krishnam Raju Kunaparaju Managing Director 21 Aug 2020 Current
Mohan Vamsy Chigurupati Director 21 Aug 2020 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Sep 2022 Past
Pramod Abcsdd Director 24 Sep 2021 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Bhimavaram Institute Of Oncology.

Bhimavaram Institute Of Oncology Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 335.7%.

Bhimavaram Institute Of Oncology revenue growth over time
Bhimavaram Institute Of Oncology profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 15667.49%
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
 335.70%
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Bhimavaram Institute Of Oncology?

In 2022, Bhimavaram Institute Of Oncology had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹106,517,500.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Yes Bank Limited : 10.65 Cr
Latest Charge Details
Date Lender Amount Status
29 Sep 2021 Yes Bank Limited ₹10.65 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Bhimavaram Institute Of Oncology?

Bhimavaram Institute Of Oncology has a workforce of 43 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Bhimavaram Institute Of Oncology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bhimavaram Institute Of Oncology's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Bhimavaram Institute Of Oncology
Recent Activity within the Organization
  • Annual General Meeting

    The activity Bhimavaram Institute Of Oncology Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Bhimavaram Institute Of Oncology Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Vijayawada. was documented.

  • Director Appointment

    Progress on Hara Govind Chigurupati was appointed as a Director was appointed as a Director on 01 Oct 2021 & has been associated with this company since 4 years 5 months . was documented.

  • Charges

    The activity A charge with Yes Bank Limited amounted to Rs. 10.65 Cr with Charge ID 100495888 was registered on 29 Sep 2021. was completed.

  • Director Appointment

    Gopala Raju Gadiraju was appointed as a Director was appointed as a Director on 21 Aug 2020 & has been associated with this company since 5 years 6 months . was recorded as a recent event.

  • Director Appointment

    Progress on Venkata Naga Murali Krishnam Raju Kunaparaju was appointed as a Managing Director was appointed as a Managing Director on 21 Aug 2020 & has been associated with this company since 5 years 6 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Bhimavaram Institute Of Oncology Private Limited?

The CIN of Bhimavaram Institute Of Oncology Private Limited is U85100AP2020PTC115422.

Where is Bhimavaram Institute Of Oncology Private Limited headquartered?

Bhimavaram Institute Of Oncology Private Limited is headquartered at C/O Kvnmk Raju,Bhimavaram Hospitals Ltd, Opp S R K R Engg. College, W.G.District, Bhimavaram, Andhra Pradesh, 534201.

When was Bhimavaram Institute Of Oncology Private Limited incorporated?

Bhimavaram Institute Of Oncology Private Limited was incorporated on 21 August 2020.

Who are the current directors of Bhimavaram Institute Of Oncology Private Limited?

The current directors of Bhimavaram Institute Of Oncology Private Limited are

What is the primary industry of Bhimavaram Institute Of Oncology Private Limited?

The primary industry of Bhimavaram Institute Of Oncology Private Limited is Healthcare.

Is Bhimavaram Institute Of Oncology Private Limited a listed company?

Bhimavaram Institute Of Oncology Private Limited is unlisted.

What is the capital structure of Bhimavaram Institute Of Oncology Private Limited?

The authorized capital of Bhimavaram Institute Of Oncology Private Limited is ₹10.00 Cr, and the paid-up capital is ₹8.50 Cr.

What is the compliance status of Bhimavaram Institute Of Oncology Private Limited?

The compliance status of Bhimavaram Institute Of Oncology Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available